Author: Bill Snyder
Goldenring’s gastrointestinal research contributions lauded
Mar. 23, 2023—Vanderbilt's James Goldenring, MD, PhD, has been honored by the American Gastroenterological Association for making significant contributions to understanding gastrointestinal disease.
Scientists resurrect a ‘dead’ antibody to study protein
Mar. 16, 2023—Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.
Cardiovascular research pioneer Inagami mourned
Mar. 16, 2023—Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.
Ashcroft named to receive Vanderbilt Prize in Biomedical Science
Mar. 15, 2023—Professor Dame Frances Ashcroft, a British physiologist known internationally for her work on insulin secretion, Type 2 diabetes and neonatal diabetes, is the recipient of the 2023 Vanderbilt Prize in Biomedical Science.
Study finds RSV may evade vaccines via rapid mutation
Mar. 9, 2023—A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.
Study finds chronically disrupted sleep may increase risk for heart disease
Feb. 15, 2023—Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.
Team’s imaging strategy enhances lipedema treatment
Feb. 9, 2023—A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.
VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people
Feb. 6, 2023—Vanderbilt University Medical Center's ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.
Researchers clarify role of blood cell mutations in disease
Feb. 2, 2023—Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.
Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections
Feb. 2, 2023— by Bill Snyder More than a million people in the United States are living with HIV, the virus that causes AIDS. One-fifth of them have been co-infected by the hepatitis C virus (HCV), which attacks the liver. Curative drugs for HCV are available, but many people don’t know they’ve been infected. And if they...
Nobel laureate Nurse set for year’s first Discovery Lecture
Jan. 26, 2023—Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year's first Discovery Lecture.
Study reveals new genetic disorder that causes susceptibility to opportunistic infections
Jan. 20, 2023—An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia.
